Skip to content

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04619823
Acronym
VIRIMA
Enrollment
250
Registered
2020-11-06
Start date
2021-02-15
Completion date
2026-02-15
Last updated
2024-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arbovirus Infections, Chikungunya, Dengue, Zika

Keywords

New Caledonia

Brief summary

Arboviruses, diseases transmitted to humans by the bite of an insect vector, are a major public health problem, particularly in tropical and sub-tropical countries. In New Caledonia, dengue epidemics are recurrent and may be associated with the co-circulation of other arboviruses such as Zika or chikungunya. The virological determinants which condition the occurrence of these epidemics may be linked to an increased vectorial competence of the vector mosquito Aedes aegypti for a particular viral isolate. In fact, the Aedes aegypti mosquito is infected by making a blood meal on a person infected with an arbovirus. The virus infects its digestive tract, then spreads throughout the mosquito's body until it reaches its salivary glands. The virus is then present in the saliva and will be injected into the human host during a new blood meal. Some viral variants are best transmitted by Aedes aegypti. In general, the study of this vectorial competence is carried out by experiments in the laboratory during which an artificial blood meal composed of mammalian blood (human, rabbit, etc.) is mixed with a viral stock. Carrying out deported blood meals during which blood collected from patients infected with an arbovirus is used to gorge mosquitoes makes it possible to place oneself in experimental conditions as close as possible to the natural cycle of transmission of arboviruses. In the human host, cells of the myeloid lineage present in the peripheral blood constitute preferred targets of replication for arboviruses. At the same time, the peripheral blood cells of patients are activated in response to infection and secrete many soluble factors released into the blood of patients. The study of blood samples from patients infected with arboviruses is therefore of prime importance for understanding both the replicative mechanisms of arboviruses but also the immune response they induce.

Detailed description

Collection of blood samples from adult patients with clinical signs suggestive of arbovirus This study is a interventional study that present minimal risks and constraints. This study will improve : * the reliability of the results of vector competence experiments * the understanding of the mechanisms of infection and replication of arboviruses * the knowledge of the immune mechanisms involved in the response to infection by an arbovirus

Interventions

OTHERBlood sample collection

Blood sample collection Mosquito collection at home

Sponsors

Institut Pasteur de Nouvelle-Calédonie
CollaboratorUNKNOWN
Centre Hospitalier Territorial de Nouvelle-Calédonie
CollaboratorOTHER
Institut Pasteur
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major patient * Patient with clinical signs suggestive of an arbovirus infection: Fever And at least 2 clinical signs suggestive of arbovirus among which myalgia, retro-orbital pain, drop in platelets (if data available), digestive symptoms, etc. * Appearance of clinical signs suggestive of an arbovirus infection in the 7 days preceding the blood sample. * Patient informed of the performance of the research, the collection of data and biological samples * Patient who has given their consent to participate in the research by authorizing the collection of data, the collection of an additional blood sample and the use of this sample

Exclusion criteria

* Patient suffering from another identified virosis, an inflammatory disease or taking anti-inflammatory drugs * Pregnant patient * Patient returning from a trip within 15 days before the onset of the signs, * Patient for whom the blood sample is incomplete or could not be performed * Patient's condition, which, in the doctor's opinion, is incompatible with the additional sample required by the study * Patient not having consented to participate in the research

Design outcomes

Primary

MeasureTime frameDescription
Measurement of vector competence parameters of Aedes aegypti (carriers or not of Wolbachia) for arboviruses by vector competence experiments using deported blood meals.5 yearsRate of infection of Aedes aegypti (carriers or not of Wolbachia) for arboviruses

Secondary

MeasureTime frameDescription
Molecular characterization of arborviruses strains included in the blood of patients and which may be diffused by mosquitoes carrying Wolbachia or not during deported blood meals5 yearsWhole genome sequencing and bioinformatics techniques as well as by in vitro infections of arbovirus strains included in the blood of patients and which may be diffused by mosquitoes carrying Wolbachia or not during deported blood meals
Molecular characterization of arborviruses strains contained in mosquitoes present in patients' homes5 yearsWhole genome sequencing and bioinformatics techniques as well as by in vitro infections of arbovirus strains contained in mosquitoes present in patients' homes

Countries

New Caledonia

Contacts

Primary ContactMyrielle Dupont-Rouzeyrol, PhD
mdupont@pasteur.nc+687 27 75 30
Backup ContactCatherine Inizan, PhD
cinizan@pasteur.fr+687 27 26 66

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026